Monoclonal Mouse anti‑Human HOXC13 Antibody (clone 10D201, Azide‑free, aa132‑232, WB) LS‑C183693
Monoclonal Mouse anti‑Human HOXC13 Antibody (clone 10D201, Azide‑free, aa132‑232, WB) LS‑C183693
Antibody:
HOXC13 Mouse anti-Human Monoclonal (aa132-232) (Azide-free) (10D201) Antibody
Format:
Unconjugated, Azide-free
Overview
Antibody:
HOXC13 Mouse anti-Human Monoclonal (aa132-232) (Azide-free) (10D201) Antibody
Format:
Unconjugated, Azide-free
Specifications
Description
HOXC13 antibody LS-C183693 is an unconjugated mouse monoclonal antibody to human HOXC13 (aa132-232). Validated for ELISA and WB.
Target
Human HOXC13
Synonyms
HOXC13 | Homeo box C13 | Homeobox protein Hox-3G | Homeobox protein Hox-C13 | Homeo box 3G | HOX3G | ECTD9 | Homeobox C13 | HOX3 | NUP98/HOXC13
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1,k
Monoclonal
Conjugations
Unconjugated.
Also available conjugated with
APC,
Biotin,
FITC,
HRP,
PE.
Immunogen
Recombinant protein corresponding to aa132-232 of human HOXC13 with GST tag (MW of GST tag: ~26kD).
Specificity
Human HOXC13.
Usage
The applications listed have been tested for the unmodified form of this product. Other forms have not been tested.
Presentation
PBS, pH 7.2, No preservatives added, Sodium Azide free
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot
Species:
Bovine
Applications:
Flow Cytometry
Reactivity:
Horse
Range:
0.156-10 µg/ml
Reactivity:
Human, Mouse, Rat
Range:
Positive/Negative
Species:
Rat, Human, Mouse, Rabbit, Chicken, Snake
Applications:
IHC, IHC - Paraffin, IHC - Frozen, Western blot, ELISA
Reactivity:
Dog
Range:
3.12-200 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/19/2024